Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Rodríguez-Novoa, S.
785  Ergebnisse:
Personensuche X
?
1

832 MONITORING OF FACTORS RELATED TO PLASMA CONCENTRATION O..:

Jiménez Macías, F.M. ; Rodríguez-Novoa, S. ; Alvárez Barco, E....
Journal of Hepatology.  58 (2013)  - p. S341 , 2013
Link: https://doi.org/10.1016/..
 
?
2

Impact of Inosine Triphosphatase Gene Variants on the Risk ..:

Rallon, N. I. ; Morello, J. ; Labarga, P....
Clinical Infectious Diseases.  53 (2011)  12 - p. 1291-1295 , 2011
Link: https://doi.org/10.1093/..
 
?
3

Use of the HCP5 single nucleotide polymorphism to predict h..:

Rodriguez-Novoa, S. ; Cuenca, L. ; Morello, J....
Journal of Antimicrobial Chemotherapy.  65 (2010)  8 - p. 1567-1569 , 2010
Link: https://doi.org/10.1093/..
 
?
4

1008 KIDNEY TUBULAR DYSFUNCTION (KTD) IN PATIENTS WITH PROL..:

Labarga, P. ; Barreiro, P. ; Rodriguez-Novoa, S....
Journal of Hepatology.  52 (2010)  - p. S389 , 2010
Link: https://doi.org/10.1016/..
 
?
5

282 A SPECIFIC HAPLOTYPE AT THE ENT1 GENE INFLUENCES THE RA..:

Morello, J. ; Cuenca, L. ; Soriano, V....
Journal of Hepatology.  52 (2010)  - p. S118 , 2010
Link: https://doi.org/10.1016/..
 
?
6

1160 HEPATIC SAFETY PROFILE OF NEW ANTIRETROVIRAL DRUGS IN ..:

Vispo, E. ; Mena, A. ; Maida, I....
Journal of Hepatology.  52 (2010)  - p. S448 , 2010
Link: https://doi.org/10.1016/..
 
?
7

648 DIFFERENCES IN ANTIVIRAL ACTIVITY AND TOLERABILITY BETW..:

Vispo, E. ; Tuma, P. ; Medrano, J....
Journal of Hepatology.  50 (2009)  - p. S238-S239 , 2009
Link: https://doi.org/10.1016/..
 
?
8

Hepatic safety profile of raltegravir in HIV-infected patie..:

Vispo, E. ; Mena, A. ; Maida, I....
Journal of Antimicrobial Chemotherapy.  65 (2009)  3 - p. 543-547 , 2009
Link: https://doi.org/10.1093/..
 
?
9

Kidney tubular abnormalities in HIV patients treated with t..:

Labarga, P ; Barreiro, P ; Martin-Carbonero, L...
Journal of the International AIDS Society.  11 (2008)  Suppl 1 - p. P128 , 2008
Link: https://doi.org/10.1186/..
 
?
10

Trends in the prescription of antiretroviral drugs and impa..:

Jimenez-Nacher, I. ; Garcia, B. ; Barreiro, P....
Journal of Antimicrobial Chemotherapy.  62 (2008)  4 - p. 816-822 , 2008
Link: https://doi.org/10.1093/..
 
?
11

Simplification from TPV/RTV 500/200 BID to TPV/RTV 500/100 ..:

Morello, J ; Rodríguez-Nóvoa, S ; Blanco, F...
Journal of the International AIDS Society.  11 (2008)  S1 - p. , 2008
Link: https://doi.org/10.1186/..
 
?
12

838 DISTINCT HEPATITIS C VIRUS KINETICS IN HIV+ PATIENTS TR..:

Vispo, E. ; Barreiro, P. ; Rodríguez-Novoa, S....
Journal of Hepatology.  48 (2008)  - p. S314 , 2008
Link: https://doi.org/10.1016/..
 
?
13

801 RESCUE THERAPY WITH OPTIMIZED PEG-INTERFERON PLUS RIBAV..:

Labarga, P. ; Vispo, M.E. ; Barreiro, P....
Journal of Hepatology.  48 (2008)  - p. S299 , 2008
Link: https://doi.org/10.1016/..
 
?
14

Usefulness of monitoring ribavirin plasma concentrations to..:

Morello, J. ; Rodriguez-Novoa, S. ; Jimenez-Nacher, I..
Journal of Antimicrobial Chemotherapy.  62 (2008)  6 - p. 1174-1180 , 2008
Link: https://doi.org/10.1093/..
 
?
15

Raltegravir: a potent and safe integrase inhibitor with a f..:

Blanco, F ; Arredondo, M ; Guevara, F...
Journal of the International AIDS Society.  11 (2008)  Suppl 1 - p. P20 , 2008
Link: https://doi.org/10.1186/..
 
1-15